• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上尿路尿路上皮癌的人口统计学因素与预后的关联:一项系统评价和荟萃分析。

Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis.

作者信息

Kim Hyung Suk, Jeong Chang Wook, Kwak Cheol, Kim Hyeon Hoe, Ku Ja Hyeon

机构信息

Department of Urology, Dongguk University Ilsan Medical Center, Goyang, Korea.

Department of Urology, Seoul National University Hospital, Seoul, Korea.

出版信息

Oncotarget. 2017 Jan 31;8(5):7464-7476. doi: 10.18632/oncotarget.10708.

DOI:10.18632/oncotarget.10708
PMID:27448978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5352335/
Abstract

We aimed to assess the prognostic significance of demographic factors, including age, sex, performance status, smoking status, obesity, and race in upper urinary tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy through a systematic review and meta-analysis. We conducted PubMed search for all articles published until December 2014 according to Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) guidelines. Survival outcomes of interest were intravesical recurrence (IVR) free survival, progression free survival (PFS), cancer-specific survival (CSS), and overall survival (OS). Seventy-nine studies, including numbers of subjects ranging from 24 to 9899, met the inclusion criteria. Advanced age was significantly associated with worse PFS [hazard ratio (HR) 1.01] and OS (HR 1.05). The significant predictors of CSS were age (HR 1.02) and performance status (HR 1.35). Female gender (HR 0.81) and smoking (HR 1.38) were the significant predictors only for IVR free survival. No significant associations with survival outcomes were observed in obesity and race. Our study reveals that age is one of the most important demographic predictor of survival in UTUC. Also, male gender, poor performance status, and smoking are also significantly related to worse survival outcomes. However, large well-designed prospective studies are required to investigate the precise prognostic significance of demographics.

摘要

我们旨在通过系统评价和荟萃分析,评估在接受根治性肾输尿管切除术治疗的上尿路尿路上皮癌(UTUC)患者中,包括年龄、性别、体能状态、吸烟状况、肥胖和种族在内的人口统计学因素的预后意义。我们根据系统评价和荟萃分析的首选报告项目(PRISMA)指南,在PubMed上检索了截至2014年12月发表的所有文章。感兴趣的生存结局为无膀胱内复发(IVR)生存、无进展生存(PFS)、癌症特异性生存(CSS)和总生存(OS)。79项研究符合纳入标准,研究对象数量从24至9899不等。高龄与较差的PFS(风险比[HR] 1.01)和OS(HR 1.05)显著相关。CSS的显著预测因素为年龄(HR 1.02)和体能状态(HR 1.35)。女性(HR 0.81)和吸烟(HR 1.38)仅为无IVR生存的显著预测因素。未观察到肥胖和种族与生存结局有显著关联。我们的研究表明,年龄是UTUC患者生存的最重要人口统计学预测因素之一。此外,男性、体能状态差和吸烟也与较差的生存结局显著相关。然而,需要大型设计良好的前瞻性研究来调查人口统计学因素的确切预后意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562e/5352335/cd49fce459be/oncotarget-08-7464-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562e/5352335/f7d2bddb6804/oncotarget-08-7464-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562e/5352335/0b3200867467/oncotarget-08-7464-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562e/5352335/1f6f57ff73b4/oncotarget-08-7464-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562e/5352335/71353729146d/oncotarget-08-7464-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562e/5352335/cd49fce459be/oncotarget-08-7464-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562e/5352335/f7d2bddb6804/oncotarget-08-7464-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562e/5352335/0b3200867467/oncotarget-08-7464-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562e/5352335/1f6f57ff73b4/oncotarget-08-7464-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562e/5352335/71353729146d/oncotarget-08-7464-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/562e/5352335/cd49fce459be/oncotarget-08-7464-g005.jpg

相似文献

1
Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis.上尿路尿路上皮癌的人口统计学因素与预后的关联:一项系统评价和荟萃分析。
Oncotarget. 2017 Jan 31;8(5):7464-7476. doi: 10.18632/oncotarget.10708.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
4
First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis.一线治疗成人晚期肾细胞癌:系统评价和网络荟萃分析。
Cochrane Database Syst Rev. 2023 May 4;5(5):CD013798. doi: 10.1002/14651858.CD013798.pub2.
5
Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.对早期预后不良或晚期霍奇金淋巴瘤患者,比较包括强化BEACOPP方案的一线化疗与包括ABVD方案的化疗。
Cochrane Database Syst Rev. 2017 May 25;5(5):CD007941. doi: 10.1002/14651858.CD007941.pub3.
6
Diagnosis and kidney-sparing treatments for upper tract urothelial carcinoma: state of the art.上尿路尿路上皮癌的诊断与保留肾单位治疗:现状
Minerva Urol Nefrol. 2018 Jun;70(3):242-251. doi: 10.23736/S0393-2249.18.03058-8. Epub 2018 Feb 1.
7
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.未治疗的霍奇金淋巴瘤患者化疗和放疗在第二原发性恶性肿瘤、总生存期和无进展生存期方面的优化:个体参与者数据分析
Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD008814. doi: 10.1002/14651858.CD008814.pub2.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
9
Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.治疗胶质母细胞瘤进展或复发的选择:网络荟萃分析。
Cochrane Database Syst Rev. 2021 May 4;5(1):CD013579. doi: 10.1002/14651858.CD013579.pub2.
10
The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis.根治性肾输尿管切除术治疗上尿路尿路上皮癌患者中淋巴管侵犯的影响:一项全面更新的系统评价和荟萃分析。
Urol Oncol. 2022 Jun;40(6):243-261. doi: 10.1016/j.urolonc.2022.01.014. Epub 2022 Feb 28.

引用本文的文献

1
Optimal treatment strategy and prognostic analysis for patients with locally advanced Upper Tract Urothelial Carcinoma.局部晚期上尿路尿路上皮癌患者的最佳治疗策略及预后分析
Front Surg. 2025 Jun 2;12:1548191. doi: 10.3389/fsurg.2025.1548191. eCollection 2025.
2
Upper Tract Urothelial Carcinoma: A Narrative Review of Current Surveillance Strategies for Non-Metastatic Disease.上尿路尿路上皮癌:非转移性疾病当前监测策略的叙述性综述
Cancers (Basel). 2023 Dec 20;16(1):44. doi: 10.3390/cancers16010044.
3
Upper Tract Urothelial Carcinoma (UTUC) Diagnosis and Risk Stratification: A Comprehensive Review.

本文引用的文献

1
Effect of sex on prognosis of urothelial carcinoma: propensity score matching analysis.性别对尿路上皮癌预后的影响:倾向评分匹配分析
Clin Genitourin Cancer. 2015 Apr;13(2):e113-21. doi: 10.1016/j.clgc.2014.09.006. Epub 2014 Nov 4.
2
Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experience.辅助化疗方案对高危上尿路尿路上皮癌患者临床结局的影响:日本多机构经验。
J Urol. 2015 Apr;193(4):1122-8. doi: 10.1016/j.juro.2014.10.022. Epub 2014 Oct 13.
3
Bimodal pattern of the impact of body mass index on cancer-specific survival of upper urinary tract urothelial carcinoma patients.
上尿路尿路上皮癌(UTUC)的诊断与风险分层:综述
Cancers (Basel). 2023 Oct 14;15(20):4987. doi: 10.3390/cancers15204987.
4
Predictive Value of Flank Pain and Gross Hematuria on Long-Term Survival in Patients With Upper Tract Urothelial Carcinoma Treated by Radical Nephroureterectomy.胁腹痛和肉眼血尿对上尿路尿路上皮癌患者行根治性肾输尿管切除术后长期生存的预测价值
Clin Med Insights Oncol. 2023 Jan 16;17:11795549221147993. doi: 10.1177/11795549221147993. eCollection 2023.
5
MicroRNA Signatures in the Upper Urinary Tract Urothelial Carcinoma Scenario: Ready for the Game Changer?上尿路尿路上皮癌中的 microRNA 特征:准备好改变游戏规则了吗?
Int J Mol Sci. 2022 Feb 26;23(5):2602. doi: 10.3390/ijms23052602.
6
Characteristics of upper urinary tract urothelial carcinoma in the context of bladder cancer: a narrative review.膀胱癌背景下上尿路尿路上皮癌的特征:一项叙述性综述。
Transl Androl Urol. 2021 Oct;10(10):4036-4050. doi: 10.21037/tau-20-1472.
7
The Impact of Diabetes on the Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Systematic Review and Meta-Analysis.糖尿病对根治性肾输尿管切除术后上尿路尿路上皮癌预后的影响:一项系统评价和荟萃分析。
Front Oncol. 2021 Oct 18;11:741145. doi: 10.3389/fonc.2021.741145. eCollection 2021.
8
Association Between Preoperative Hydronephrosis and Prognosis After Radical Cystectomy Among Patients With Bladder Cancer: A Systemic Review and Meta-Analysis.膀胱癌患者根治性膀胱切除术前肾积水与预后的关联:一项系统评价和Meta分析
Front Oncol. 2019 Mar 19;9:158. doi: 10.3389/fonc.2019.00158. eCollection 2019.
9
Laparoscopy versus Open Nephroureterectomy in Prognostic Outcome of Patients with Advanced Upper Tract Urothelial Cancer: A Retrospective, Multicenter, Propensity-Score Matching Analysis.腹腔镜与开放性肾输尿管切除术治疗晚期上尿路尿路上皮癌患者预后的比较:一项回顾性、多中心、倾向评分匹配分析。
Cancer Res Treat. 2019 Jul;51(3):963-972. doi: 10.4143/crt.2018.465. Epub 2018 Oct 12.
10
STAT3 expression is a prognostic marker in upper urinary tract urothelial carcinoma.STAT3 表达是上尿路上皮癌的预后标志物。
PLoS One. 2018 Aug 9;13(8):e0201256. doi: 10.1371/journal.pone.0201256. eCollection 2018.
体重指数对上尿路尿路上皮癌患者癌症特异性生存影响的双峰模式。
Anticancer Res. 2014 Oct;34(10):5683-8.
4
Possible role of template-based lymphadenectomy in reducing the risk of regional node recurrence after nephroureterectomy in patients with renal pelvic cancer.基于模板的淋巴结清扫术在降低肾盂癌患者肾输尿管切除术后区域淋巴结复发风险中的可能作用。
Jpn J Clin Oncol. 2014 Dec;44(12):1233-8. doi: 10.1093/jjco/hyu151. Epub 2014 Sep 30.
5
Conditional survival after radical nephroureterectomy for upper tract carcinoma.根治性肾输尿管切除术治疗上尿路尿路上皮癌的条件生存。
Eur Urol. 2015 Apr;67(4):803-12. doi: 10.1016/j.eururo.2014.08.003. Epub 2014 Aug 19.
6
Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.血清术前C反应蛋白:根治性肾输尿管切除术治疗上尿路尿路上皮癌的预后生物标志物。
Urol Int. 2014;93(3):352-60. doi: 10.1159/000362248. Epub 2014 Aug 19.
7
Impact of surgical wait time on oncologic outcomes in upper urinary tract urothelial carcinoma.手术等待时间对上尿路上皮癌肿瘤学结局的影响。
J Surg Oncol. 2014 Sep;110(4):468-75. doi: 10.1002/jso.23589. Epub 2014 Jul 25.
8
Predictors of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: an inflammation-based prognostic score.上尿路尿路上皮癌根治性肾输尿管切除术后膀胱内复发的预测因素:一种基于炎症的预后评分
Korean J Urol. 2014 Jul;55(7):453-9. doi: 10.4111/kju.2014.55.7.453. Epub 2014 Jul 11.
9
Comparison of laparoscopic, hand-assisted, and open surgical nephroureterectomy.腹腔镜、手辅助及开放手术肾输尿管切除术的比较
JSLS. 2014 Apr-Jun;18(2):288-93. doi: 10.4293/108680813X13794522666842.
10
Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.中性粒细胞与淋巴细胞比值及红细胞沉降率在接受上尿路尿路上皮癌根治性肾输尿管切除术患者预后中的临床意义
BJU Int. 2015 Apr;115(4):587-94. doi: 10.1111/bju.12846. Epub 2014 Dec 7.